Medical Journals

Stromal Fibroblasts in Cancer: a Novel Tumor-promoting Cell Type.

Authors:
  • Orimo Akira
  • Weinberg Robert A

From: Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA.

Cell cycle (Georgetown, Tex.)

  • Publish Date: Aug 2006
  • ISSN: 1551-4005
  • Volume: 5
  • Issue: 15
  • Pages: 1597-601
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Orimo Akira, Weinberg Robert A, et al. Stromal Fibroblasts in Cancer: a Novel Tumor-promoting Cell Type.. Cell Cycle Aug 2006;5:1597-601

Abstract

Tumors are highly complex tissues composed of neoplastic cells and, in the case of carcinomas, stromal cell compartments containing a variety of mesenchymal cells, notably fibroblasts, myofibroblasts, endothelial cells, pericytes, and a variety of inflammatory cells associated with the immune system. Fibroblasts and myofibroblasts often represent the majority of the stromal cells within various types of human carcinomas, yet the specific contributions of these cells to tumor growth are poorly understood. Recent work has demonstrated that stromal fibroblast fractions, named carcinoma-associated fibroblasts (CAFs), that have been extracted from a number of invasive human breast carcinomas are more competent to promote the growth of mammary carcinoma cells and to enhance tumor angiogenesis than are comparable cells derived from outside of these tumor masses. CAFs include large populations of myofibroblasts that secrete elevated levels of stromal cell-derived factor 1 (SDF-1), also called CXCL12, which plays a central role in the promotion of tumor growth and angiogenesis; CAF-derived SDF-1 not only stimulates carcinoma cell growth directly through the CXCR4 receptor displayed on tumor cells but also serves to recruit endothelial progenitor cells (EPCs) into tumors, thereby furthering neoangiogenesis. In this review, we highlight the importance of this SDF-1-CXCR4 signaling pathway in the tumor microenvironment and discuss the mechanisms by which stromal fibroblasts within mammary carcinomas enhance tumor growth.

Mesh Headings (Keywords): Animals, Chemokine CXCL12, Chemokines, CXC, Epigenesis, Genetic, Fibroblasts, Humans, Neoplasms, Receptors, CXCR4, Stromal Cells


Check for Full Text / PubMed Unique Identifier (PMID): 16880743


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.